Overview
This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.
Description
This study aims to examine the effect of cannabidiol (CBD), pre-treatment, as Epidiolex, on brain microglial activation in healthy human subjects using [11C]PBR28 PET imaging. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects. Lastly, this research study will also examine the relationship between brain microglial activation and central pain sensitization with CBD pre-treatment.
Eligibility
Inclusion Criteria:
- Men and women aged 18- 55 years
- No significant medical or neurological illness
- No implanted metal devices that may pose a risk during MRI scanning
- Within the annual permissible radiation exposure
- Able to provide written informed consent.
Exclusion Criteria:
- Current use of any medications
- Presence of metal in the body
- Pregnancy or lactation